{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:45:13Z","timestamp":1791308713721,"version":"4.3.1"},"reference-count":55,"publisher":"The Company of Biologists","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6,15]]},"abstract":"<jats:p>Differentiated cells can be reprogrammed to pluripotency and other cell fates by treatment with defined factors. The discovery of induced pluripotent stem cells (iPSCs) has opened up unprecedented opportunities in the pharmaceutical industry, in the clinic and in laboratories. In particular, the medical applications of human iPSCs in disease modeling and stem cell therapy have been progressing rapidly. The ability to induce cell fate conversion is attractive not only for these applications, but also for basic research fields, such as development, cancer, epigenetics and aging.<\/jats:p>","DOI":"10.1242\/dev.092551","type":"journal-article","created":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T00:14:02Z","timestamp":1369786442000},"page":"2457-2461","source":"Crossref","is-referenced-by-count":233,"title":["Induced pluripotent stem cells in medicine and biology"],"prefix":"10.1242","volume":"140","author":[{"given":"Kazutoshi","family":"Takahashi","sequence":"first","affiliation":[{"name":"Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Yamanaka","sequence":"additional","affiliation":[{"name":"Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan"},{"name":"Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","reference":[{"key":"2021042607185553900_R1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature11807","article-title":"Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells","volume":"494","author":"Araki","year":"2013","journal-title":"Nature"},{"key":"2021042607185553900_R2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrm3448","article-title":"Induced pluripotent stem cells: the new patient?","volume":"13","author":"Bellin","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2021042607185553900_R3","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/biot.201100347","article-title":"Mediators of induced pluripotency and their role in cancer cells \u2013 current scientific knowledge and future perspectives","volume":"7","author":"Bernhardt","year":"2012","journal-title":"Biotechnol. J."},{"key":"2021042607185553900_R4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature05950","article-title":"Derivation of pluripotent epiblast stem cells from mammalian embryos","volume":"448","author":"Brons","year":"2007","journal-title":"Nature"},{"key":"2021042607185553900_R5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.stem.2010.05.003","article-title":"A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells","volume":"6","author":"Buecker","year":"2010","journal-title":"Cell Stem Cell"},{"key":"2021042607185553900_R6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nature10284","article-title":"Direct generation of functional dopaminergic neurons from mouse and human fibroblasts","volume":"476","author":"Caiazzo","year":"2011","journal-title":"Nature"},{"key":"2021042607185553900_R7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0092-8674(03)00392-1","article-title":"Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells","volume":"113","author":"Chambers","year":"2003","journal-title":"Cell"},{"key":"2021042607185553900_R8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nmeth.1593","article-title":"Chemically defined conditions for human iPSC derivation and culture","volume":"8","author":"Chen","year":"2011","journal-title":"Nat. Methods"},{"key":"2021042607185553900_R9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0092-8674(87)90585-X","article-title":"Expression of a single transfected cDNA converts fibroblasts to myoblasts","volume":"51","author":"Davis","year":"1987","journal-title":"Cell"},{"key":"2021042607185553900_R10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/146608201300079364","article-title":"A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group","volume":"2","author":"Desnuelle","year":"2001","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"key":"2021042607185553900_R11","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1158799","article-title":"Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons","volume":"321","author":"Dimos","year":"2008","journal-title":"Science"},{"key":"2021042607185553900_R12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature07677","article-title":"Induced pluripotent stem cells from a spinal muscular atrophy patient","volume":"457","author":"Ebert","year":"2009","journal-title":"Nature"},{"key":"2021042607185553900_R13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/FJC.0b013e318247f642","article-title":"Induced pluripotent stem cells as a disease modeling and drug screening platform","volume":"60","author":"Ebert","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"2021042607185553900_R14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.stem.2008.09.002","article-title":"Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals","volume":"3","author":"Eiraku","year":"2008","journal-title":"Cell Stem Cell"},{"key":"2021042607185553900_R15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature09941","article-title":"Self-organizing optic-cup morphogenesis in three-dimensional culture","volume":"472","author":"Eiraku","year":"2011","journal-title":"Nature"},{"key":"2021042607185553900_R16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.stem.2009.09.008","article-title":"Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2","volume":"5","author":"Giorgetti","year":"2009","journal-title":"Cell Stem Cell"},{"key":"2021042607185553900_R17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.stem.2010.01.003","article-title":"Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells","volume":"6","author":"Greber","year":"2010","journal-title":"Cell Stem Cell"},{"key":"2021042607185553900_R18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.stem.2013.01.006","article-title":"Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells","volume":"12","author":"Guha","year":"2013","journal-title":"Cell Stem Cell"},{"key":"2021042607185553900_R19","first-page":"622","article-title":"The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles","volume":"10","author":"Gurdon","year":"1962","journal-title":"J. Embryol. Exp. Morphol."},{"key":"2021042607185553900_R20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.stem.2009.08.021","article-title":"Generation of induced pluripotent stem cells from human cord blood","volume":"5","author":"Haase","year":"2009","journal-title":"Cell Stem Cell"},{"key":"2021042607185553900_R21","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1126\/science.1152092","article-title":"Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin","volume":"318","author":"Hanna","year":"2007","journal-title":"Science"},{"key":"2021042607185553900_R22","doi-asserted-by":"crossref","first-page":"9222","DOI":"10.1073\/pnas.1004584107","article-title":"Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs","volume":"107","author":"Hanna","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042607185553900_R23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cell.2011.06.052","article-title":"Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells","volume":"146","author":"Hayashi","year":"2011","journal-title":"Cell"},{"key":"2021042607185553900_R24","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1226889","article-title":"Offspring from oocytes derived from in vitro primordial germ cell-like cells in mice","volume":"338","author":"Hayashi","year":"2012","journal-title":"Science"},{"key":"2021042607185553900_R25","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nbt.1562","article-title":"Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases","volume":"27","author":"Hockemeyer","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"2021042607185553900_R26","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nbt.1927","article-title":"Genetic engineering of human pluripotent cells using TALE nucleases","volume":"29","author":"Hockemeyer","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"2021042607185553900_R27","doi-asserted-by":"crossref","first-page":"12538","DOI":"10.1073\/pnas.1209979109","article-title":"Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells","volume":"109","author":"Kajiwara","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042607185553900_R28","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cell.2010.07.039","article-title":"Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells","volume":"142","author":"Kobayashi","year":"2010","journal-title":"Cell"},{"key":"2021042607185553900_R29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0092-8674(03)00393-3","article-title":"The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells","volume":"113","author":"Mitsui","year":"2003","journal-title":"Cell"},{"key":"2021042607185553900_R30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1634\/stemcells.2006-0566","article-title":"Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy","volume":"25","author":"Nakajima","year":"2007","journal-title":"Stem Cells"},{"key":"2021042607185553900_R31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.stem.2012.11.002","article-title":"Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation","volume":"12","author":"Nishimura","year":"2013","journal-title":"Cell Stem Cell"},{"key":"2021042607185553900_R32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","article-title":"A more efficient method to generate integration-free human iPS cells","volume":"8","author":"Okita","year":"2011","journal-title":"Nat. Methods"},{"key":"2021042607185553900_R33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/stem.1293","article-title":"An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells","volume":"31","author":"Okita","year":"2013","journal-title":"Stem Cells"},{"key":"2021042607185553900_R34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nbt1383","article-title":"Marked differences in differentiation propensity among human embryonic stem cell lines","volume":"26","author":"Osafune","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"2021042607185553900_R35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"2021042607185553900_R36","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.4161\/cc.10.19.17584","article-title":"Efficient induction of functional neurons from adult human fibroblasts","volume":"10","author":"Pfisterer","year":"2011","journal-title":"Cell Cycle"},{"key":"2021042607185553900_R37","doi-asserted-by":"crossref","first-page":"4A.3.1","DOI":"10.1002\/9780470151808.sc04a03s18","article-title":"Derivation of induced pluripotent stem cells from human peripheral circulating T cells","volume":"18","author":"Seki","year":"2011","journal-title":"Curr. Protoc. Stem Cell Biol."},{"key":"2021042607185553900_R38","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1212\/01.WNL.0000142992.81995.F0","article-title":"A clinical trial of creatine in ALS","volume":"63","author":"Shefner","year":"2004","journal-title":"Neurology"},{"key":"2021042607185553900_R39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.stem.2011.07.014","article-title":"Conversion of mouse and human fibroblasts into functional spinal motor neurons","volume":"9","author":"Son","year":"2011","journal-title":"Cell Stem Cell"},{"key":"2021042607185553900_R40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature10637","article-title":"Self-formation of functional adenohypophysis in three-dimensional culture","volume":"480","author":"Suga","year":"2011","journal-title":"Nature"},{"key":"2021042607185553900_R41","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1242\/jcs.084822","article-title":"Cellular reprogramming \u2013 lowering gravity on Waddington's epigenetic landscape","volume":"125","author":"Takahashi","year":"2012","journal-title":"J. Cell Sci."},{"key":"2021042607185553900_R42","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"2021042607185553900_R43","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"2021042607185553900_R44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.exphem.2009.11.003","article-title":"Effective generation of iPS cells from CD34(+). cord blood cells by inhibition of p53","volume":"38","author":"Takenaka","year":"2009","journal-title":"Exp. Hematol."},{"key":"2021042607185553900_R45","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nature05972","article-title":"New cell lines from mouse epiblast share defining features with human embryonic stem cells","volume":"448","author":"Tesar","year":"2007","journal-title":"Nature"},{"key":"2021042607185553900_R46","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"2021042607185553900_R47","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.molcel.2012.09.008","article-title":"Molecular roadblocks for cellular reprogramming","volume":"47","author":"Vierbuchen","year":"2012","journal-title":"Mol. Cell"},{"key":"2021042607185553900_R48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2012.12.006","article-title":"Regeneration of human tumor antigen-specific T cells from iPSCs derived from mature CD8(+) T cells","volume":"12","author":"Vizcardo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"2021042607185553900_R49","volume-title":"The Strategy of the Genes. A Discussion of Some Aspects of Theoretical Biology","author":"Waddington","year":"1957"},{"key":"2021042607185553900_R50","doi-asserted-by":"crossref","first-page":"18283","DOI":"10.1073\/pnas.1100893108","article-title":"Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1","volume":"108","author":"Wang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042607185553900_R51","doi-asserted-by":"crossref","DOI":"10.5962\/bhl.title.168967","volume-title":"The Germ-Plasm: A Theory of Heredity","author":"Weismann","year":"1893"},{"key":"2021042607185553900_R52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cell.2009.03.034","article-title":"A fresh look at iPS cells","volume":"137","author":"Yamanaka","year":"2009","journal-title":"Cell"},{"key":"2021042607185553900_R53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.stem.2010.06.009","article-title":"Patient-specific pluripotent stem cells become even more accessible","volume":"7","author":"Yamanaka","year":"2010","journal-title":"Cell Stem Cell"},{"key":"2021042607185553900_R54","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"2021042607185553900_R55","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","article-title":"Human induced pluripotent stem cells free of vector and transgene sequences","volume":"324","author":"Yu","year":"2009","journal-title":"Science"}],"container-title":["Development"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.biologists.com\/dev\/article-pdf\/140\/12\/2457\/1319700\/2457.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/dev\/article-pdf\/140\/12\/2457\/1319700\/2457.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T10:48:34Z","timestamp":1619434114000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dev\/article\/140\/12\/2457\/45744\/Induced-pluripotent-stem-cells-in-medicine-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,15]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,6,15]]}},"URL":"https:\/\/doi.org\/10.1242\/dev.092551","relation":{},"ISSN":["1477-9129","0950-1991"],"issn-type":[{"value":"1477-9129","type":"electronic"},{"value":"0950-1991","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6,15]]}}}